Corticosteroids are frequently used to treat rheumatic diseases. Their use comes with a
number of well-established risks including osteoporosis, avascular necrosis, glaucoma, and …

SLE is a chronic autoimmune rheumatic disorder of high heterogeneity in clinical
presentation, treatment response and prognosis. Long-term outcomes in SLE have been …

The observational association between gut microbiome and systemic lupus erythematosus
(SLE) has been well documented. However, whether the association is causal remains …

Gut microbiota dysbiosis has been observed in a number of autoimmune diseases.
However, the role of the gut microbiota in systemic lupus erythematosus (SLE), a …

Background Systemic lupus erythematosus, characterized by persistent inflammation, is a
complex autoimmune disorder with no known cure. Immunosuppressants used in treatment …

Objective To determine trends in survival among adult and paediatric patients with systemic
lupus erythematosus (SLE) from 1950 to the present. Methods We performed a systematic …

Obtaining an updated view of the epidemiology, risk factors, and prognosis of systemic lupus
erythematosus (SLE) is pivotal to our understanding of the disease burden. Recent …

Objectives The aims of this study were to update the evidence on the incidence and
prevalence rates of vaccine preventable infections (VPI) in patients with autoimmune …

The prognosis of patients with connective tissue disease (CTD) has improved significantly in
recent years, but interstitial lung disease (ILD) associated with connective tissue disease …

Objectives We conducted a systematic review and meta-analysis to determine the
magnitude of infection risk in patients with SLE and evaluate the effect of general and SLE …